Research Study

A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
Principal Investigator 
Yasser Abou Mourad

Overview

Body Locations and Systems 
Leukemia
Disorders and Conditions 
Acute Lymphocytic Leukemia
ClinicalTrials.gov# 
NCT02003222
Status 
Recruiting
Study Start/End 
Apr 18, 2018 to Sep 30, 2019
Locations 
Vancouver General Hospital
Name/Title 
Fareeha Khan
Phone 
604-875-4111 ext.22966
Purpose of Study 

The purpose of this study is to determine whether combination chemotherapy is more effective with or without blinatumomab in treating newly diagnosed acute lymphoblastic leukemia.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.